Global Genomics & Personalized Medicine Congress 2026

17-18 September 2026 | Budapest, Hungary

Welcome to the Global Genomics & Personalized Medicine Congress

The Global Genomics & Personalized Medicine Congress 2026 (GPMC 2026) is an in-person international scientific meeting positioned at the intersection of genomics, clinical innovation, and patient-centered healthcare. Scheduled for 17–18 September 2026 in Budapest, Hungary, the congress brings together researchers, clinicians, academicians, and industry innovators working to shape the next era of precision medicine.

Over two intensive days, GPMC 2026 will highlight cutting-edge developments in CRISPR-based therapeutics, AI-driven diagnostics, multi-omics integration, liquid biopsy technologies, digital twins, and pharmacogenomics, while also addressing critical challenges related to clinical translation, scalability, and equitable access to precision healthcare.

Designed as a collaborative platform for scientific exchange and real-world application, the congress encourages dialogue between academia, healthcare systems, and industry. Participants will have opportunities to share research, discuss emerging technologies, and explore strategies to translate genomic innovation from the research bench into routine clinical practice.

Join us in advancing a future where healthcare is increasingly precise, treatments are personalized, access is equitable, and patient outcomes are meaningfully improved.

Keynote Speakers

Professor Amedeo Amedei

Full Professor in Immunology, Department of Experimental Medicine, University of Florence, Italy

Key Features of Our Conference Include​

Engaging Keynote Speeches

GPMC 2026 features visionary talks from globally renowned leaders in genomics, systems biology, pharmacogenomics, and precision diagnostics. These keynote addresses highlight transformative breakthroughs and chart the future of individualized medicine.

1

Oral and Poster Presentations

Researchers and clinicians will present their most recent work in areas such as multi-omics, genomic diagnostics, and bioinformatics. Oral sessions provide high-impact exposure, while poster presentations encourage in-depth discussions and networking.

2

Panel Discussions

Cross-disciplinary panels will explore emerging challenges and opportunities in precision medicine, focusing on clinical implementation, ethical considerations, data diversity, and health equity in genomics.

3

Exhibitions and Innovation Showcase

The exhibition area will highlight the latest technologies in sequencing platforms, digital health tools, biobank systems, and precision diagnostics, offering direct interaction with solution providers and innovators.

5

Networking and Collaboration Opportunities

Connect with leading experts, innovators, and peers in genomics and precision medicine through dedicated networking sessions, informal meet-ups, and collaborative forums designed to foster partnerships and exchange of ideas.

6

By attending the Global Genomics & Personalized Medicine Congress 2026, you can stay updated on the latest trends, discoveries, and breakthroughs in genomic science and targeted medicine, and contribute to the advancement of translational research and therapeutic solutions. We look forward to welcoming you at our upcoming event!

Scientific Sessions

Focus Areas Include:

  • Next-generation sequencing platforms (short/long-read, Nanopore)
  • Single-cell and spatial multi-omics technologies
  • Whole genome/exome and transcriptome analysis
  • Epigenomics and chromatin accessibility mapping
  • Genome engineering and synthetic biology tools

Read Full Session Overview
Focus Areas Include:

  • Multi-omics integration and data harmonization
  • Systems biology network modeling and pathway analysis
  • Functional annotation of non-coding and regulatory elements
  • Causal inference and perturbation-based validation
  • Single-cell and spatial systems approaches
  • Machine learning for integrative genomics

Read Full Session Overview
Focus Areas Include:

  • Clinical whole genome/exome sequencing implementation
  • Liquid biopsy and circulating tumor DNA diagnostics
  • Variant interpretation and classification guidelines
  • Pharmacogenomics and treatment optimization
  • Rapid and point-of-care genomic testing
  • Laboratory infrastructure and quality frameworks

Read Full Session Overview
Focus Areas Include:

  • Tumor genomic profiling and molecular classification
  • Targeted therapies and biomarker-driven treatment selection
  • Liquid biopsy for treatment monitoring and early detection
  • Cancer immunogenomics and neoantigen-based therapies
  • Resistance mechanisms and adaptive treatment strategies
  • Clinical implementation through molecular tumor boards

Read Full Session Overview
Focus Areas Include:

  • Key pharmacogenomic genes and variant interpretation
  • Regulatory biomarkers and clinical guidelines
  • Specialty-specific pharmacogenomic applications
  • Health informatics integration and clinical decision support
  • Health economics and implementation science
  • Direct-to-consumer and ethical considerations
  • Emerging biomarkers and advanced prediction models

Read Full Session Overview
Focus Areas Include:

  • Polygenic risk score development and validation
  • Application to common complex diseases
  • Genome-wide association studies and fine-mapping
  • Population-specific allele frequencies and ancestry considerations
  • Risk stratification models and clinical integration
  • Addressing ancestry bias and equity in genomics
  • Large-scale biobank studies and data resources

Read Full Session Overview
Focus Areas Include:

  • Gut microbiome composition and health outcomes
  • Microbiome in metabolic and immune conditions
  • Microbial diagnostics and metagenomic methodologies
  • Pharmacomicrobiomics and drug-microbiome interactions
  • Microbiome-host immune system interactions
  • FMT and microbiome-based therapeutics
  • Probiotic personalization and precision nutrition

Read Full Session Overview
Focus Areas Include:

  • Machine learning for multi-omics data interpretation
  • Deep learning architectures for genomic variant classification
  • AI-powered biomarker discovery and validation
  • Wearables, sensors, and real-time health data integration
  • Digital twins and in silico patient modeling
  • Federated learning and privacy-preserving analytics
  • Blockchain and secure genomic data ecosystems

Read Full Session Overview
Focus Areas Include:

  • Implementation frameworks and strategies in clinical genomics
  • Genomic literacy and education for providers and patients
  • Telegenetics and expanding access in rural/underserved areas
  • Economic evaluation and sustainable reimbursement models
  • Addressing global disparities in genomic data representation
  • Infrastructure challenges in low- and middle-income countries
  • Workforce development and capacity building

Read Full Session Overview
Focus Areas Include:

  • Data ownership, control, and patient rights
  • Informed consent models in genomic testing and research
  • Return of results and recontact policies
  • Public trust and ethical considerations in AI-driven genomics
  • Direct-to-consumer testing ethics and regulatory oversight
  • Genetic discrimination laws and privacy protections
  • Cultural and religious perspectives on genome use

Read Full Session Overview

Target Audience

GPMC 2026 is tailored for professionals, researchers, and innovators shaping the future of individualized healthcare through genomics and precision science. The congress is designed for:

  • Geneticists & Genomic Medicine Experts
  • Clinical Geneticists & Genetic Counselors
  • Precision Medicine Researchers & Translational Scientists
  • Molecular Biologists & Systems Biology Researchers
  • Bioinformaticians & Computational Biologists
  • Multi-Omics Experts (Genomics, Transcriptomics, Proteomics, Metabolomics)
  • AI, Machine Learning & Genomic Data Science Professionals
  • Pharmacogenomics & Drug Development Specialists
  • Clinical Researchers & Precision Medicine Trial Investigators
  • Oncologists, Cardiologists & Other Precision Care Clinicians
  • Pathologists & Molecular Diagnostics Professionals
  • Population Health & Public Health Genomics Specialists
  • Regulatory Scientists & Personalized Medicine Policy Experts
  • Biotechnology, MedTech & Genomics Industry Leaders
  • Digital Health, Diagnostics & Clinical Platform Developers
  • Startups, Innovators & Translational Commercialization Teams
  • Early-Career Researchers, PhD Scholars & Postdoctoral Fellows

Dates to Remember

Early Bird Abstract Submission Deadline

Date: March 31, 2026

Regular Abstract Submission Deadline

Date: July 31, 2026

Late-Breaking Abstract Submissions

Date: August 5-15, 2026

Presenter Registration Deadline

Date: August 15, 2026

Get in touch

Subscription Form

Contact Us

Whatsapp whatsapp